We are live on ! Find out more
HZNP

Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP

Delisted

HZNP was delisted on the 5th of October, 2023.

Back to rankings

615 hedge funds and large institutions have $23.7B invested in Horizon Therapeutics Public Limited Company Ordinary Shares in 2022 Q4 according to their latest regulatory filings, with 188 funds opening new positions, 130 increasing their positions, 241 reducing their positions, and 95 closing their positions.

New
Increased
Maintained
Reduced
Closed

393% more funds holding in top 10

Funds holding in top 10: 14 → 69 (+55)

98% more first-time investments, than exits

New positions opened: 188 | Existing positions closed: 95

79% more capital invested

Capital invested by funds: $13.3B → $23.7B (+$10.4B)

16% more funds holding

Funds holding: 530 → 615 (+85)

28% less call options, than puts

Call options by funds: $941M | Put options by funds: $1.3B

46% less repeat investments, than reductions

Existing positions increased: 130 | Existing positions reduced: 241

Holders
615
Holders Change
+85
Holders Change %
+16.04%
% of All Funds
9.89%
Holding in Top 10
69
Holding in Top 10 Change
+55
Holding in Top 10 Change %
+392.86%
% of All Funds
1.11%
New
188
Increased
130
Reduced
241
Closed
95
Calls
$941M
Puts
$1.3B
Net Calls
-$358M
Net Calls Change
-$407M

Top Buyers

1
HI
HBK Investments
Texas
+$380M
2
JP Morgan Chase
JP Morgan Chase
New York
+$371M
3
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
+$336M
4
PCM
Pentwater Capital Management
Florida
+$294M
5
SFM
Soros Fund Management
New York
+$237M

Top Sellers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$675M
2
PC
Paulson & Co
New York
-$382M
3
Barclays
Barclays
United Kingdom
-$257M
4
N
Nuveen
North Carolina
-$191M
5
Invesco
Invesco
Georgia
-$184M
Name Holding Trade Value Shares
Change 		Change in
Stake
RPAM
626
Rhenman & Partners Asset Management
Sweden
– -$8.1M -130,000 Closed
WorldQuant Millennium Advisors
627
WorldQuant Millennium Advisors
New York
– -$7.67M -123,857 Closed
ECM
628
ExodusPoint Capital Management
New York
– -$7.39M -119,485 Closed
IAIM
629
Industrial Alliance Investment Management
Quebec, Canada
– -$5.99M -96,712 Closed
Mackenzie Financial
630
Mackenzie Financial
Ontario, Canada
– -$4.92M -79,514 Closed
GTC
631
Ghost Tree Capital
New York
– -$4.64M -75,000 Closed
ABG
632
Ally Bridge Group
New York
– -$4.6M -74,262 Closed
DAM
633
Deltec Asset Management
New York
– -$4.47M -72,290 Closed
CM
634
Caption Management
Oklahoma
– -$5.1M -61,380 Closed
BCM
635
Bridgeway Capital Management
Texas
– -$2.63M -42,500 Closed
DA
636
Duality Advisers
Florida
– -$2.12M -34,196 Closed
IHAM
637
Integral Health Asset Management
New York
– -$1.86M -30,000 Closed
IA
638
Icon Advisers
Colorado
– -$1.84M -29,700 Closed
FA
639
Faithward Advisors
Pennsylvania
– -$1.76M -28,414 Closed
HCMT
640
Highland Capital Management (Tennessee)
Tennessee
– -$1.75M -28,211 Closed
MGIM
641
M&G Investment Management
United Kingdom
– -$1.66K -26,824 Closed
TI
642
Trexquant Investment
Connecticut
– -$1.61M -26,079 Closed
CIC
643
Cornercap Investment Counsel
Georgia
– -$1.59M -25,687 Closed
OPPTF
644
OPSEU Pension Plan Trust Fund
Ontario, Canada
– -$1.49M -23,628 Closed
EA
645
Emerald Advisers
Pennsylvania
– -$1.45M -23,478 Closed
AAM
646
Azzad Asset Management
Virginia
– -$1.41M -22,856 Closed
CW
647
Connectus Wealth
Ohio
– -$1.41M -22,845 Closed
CCS
648
Concentric Capital Strategies
Connecticut
– -$1.41M -22,820 Closed
JCM
649
Jag Capital Management
Missouri
– -$1.33M -21,450 Closed
CNAM
650
Campbell Newman Asset Management
Wisconsin
– -$1.3M -21,010 Closed
24 25
26
27 28

HZNP Hedge Fund Activity: Q4 2022 in Review

615 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) for Q4 2022, worth a combined $23.7B — up 79% from $13.3B a quarter earlier.

Buyers outnumbered sellers: 188 funds opened new HZNP positions and 95 closed out — a net gain of 93 holders — while 130 added to existing stakes and 241 trimmed.

The largest buyer was HBK Investments, opening a new position worth an estimated $380M. The largest seller was Janus Henderson Group, cutting an estimated $675M.

  • 615 institutional investors held Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) as of Q4 2022, up from 530 in Q3 2022.
  • Funds reported $23.7B of Horizon Therapeutics Public Limited Company Ordinary Shares stock for Q4 2022, up 79% quarter-over-quarter.
  • 188 funds opened new Horizon Therapeutics Public Limited Company Ordinary Shares positions in Q4 2022 and 95 closed out, a net change of +93 holders.
  • The largest Horizon Therapeutics Public Limited Company Ordinary Shares buyer in Q4 2022 was HBK Investments, an estimated $380M added.
  • The largest Horizon Therapeutics Public Limited Company Ordinary Shares seller in Q4 2022 was Janus Henderson Group, an estimated $675M sold.

Based on aggregated 13F filings for Q4 2022.